Maze Therapeutics, Inc. (MAZE) earnings

MAZE earnings moved a median of +0.18% by the close. Quarterly and annual MAZE reports and results, each read against the price at its own news timestamp. Back to the MAZE overview →

12 measured MAZE earnings events.

Where these MAZE earnings landedvs 12 measured MAZE earnings reactions
MAZE earningsMiddle 50% · -3.21% to +3.69%Zero: 0.00%Median: +0.18%Median +0.18%-5.00%0+5.00%
Middle 50% of MAZE earnings reactions-3.21% to +3.69%
Median reaction (to close)+0.18%
Measured reactions12
Point-in-time · zero look-ahead

Half of the 12 MAZE earnings events with a measured close landed between -3.21% and +3.69%; 58% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Maze Therapeutics, Inc. For: Jun 30SEC filing · Form 10-Q-1.56%+0.18%
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent HighlightsPress release-1.56%+0.18%
Form 10-Q Maze Therapeutics, Inc. For: Mar 31SEC filing · Form 10-Q-2.57%+3.69%
Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent HighlightsPress release-2.57%+3.69%
Form 10-K Maze Therapeutics, Inc. For: Dec 31SEC filing · Form 10-K-1.43%-20.68%
Form 10-Q Maze Therapeutics, Inc. For: Sep 30SEC filing · Form 10-Q-1.12%-4.25%
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent HighlightsPress release-1.12%-4.25%
Form 10-Q Maze Therapeutics, Inc. For: Jun 30SEC filing · Form 10-Q+0.00%-2.86%
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent HighlightsPress release+0.00%-2.86%
Form 10-Q Maze Therapeutics, Inc. For: Mar 31SEC filing · Form 10-Q+4.66%+4.76%
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming MilestonesPress release+4.66%+4.76%
Form 10-K Maze Therapeutics, Inc. For: Dec 31SEC filing · Form 10-K+3.48%+0.92%
That’s how MAZE usually reacts to earnings — get an email when it moves on news →
Keep exploring

More MAZE: analyst actions → · SEC filings → · MAZE overview →